Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Night blindness
ADR ID BADD_A03075
ADR Hierarchy
06      Eye disorders
06.02      Vision disorders
06.02.02      Blindness (excl colour blindness)
06.02.02.003      Night blindness
14      Metabolism and nutrition disorders
14.12      Vitamin related disorders
14.12.03      Fat soluble vitamin deficiencies and disorders
14.12.03.001      Night blindness
Description A disorder characterized by an inability to see clearly in dim light. [CTCAE] Failure or imperfection of vision at night or in dim light, with good vision only on bright days. (Dorland, 27th ed) [MeSH]
MedDRA Code 10029404
MeSH ID D009755; D009755; D009755
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Acquired night blindness | Blindness night | Decreased night vision | Night blindness | Night blindness (vitamin A deficiency) | Night blindness associated with vitamin A deficiency | Night blindness, unspecified | Nyctalopia | Other night blindness | Vision loss night | Vitamin A deficiency with night blindness | Night Blindness | Blindness, Night
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01893Quinidine gluconate--
BADD_D01894Quinidine sulfate--
BADD_D01895Quinine--
BADD_D01896Quinine dihydrochloride--
BADD_D01897Quinine sulfate--
BADD_D02247Topiramate--
BADD_D02261Tranexamic acid0.014288%
BADD_D02337Varenicline--
BADD_D02338Varenicline tartrate--
BADD_D02367Voltaren--
BADD_D02369Voriconazole--
The 2th Page    First    Pre   2    Total 2 Pages